Mukka Proteins confirms no encumbrance on promoter shares in FY26

1 min read     Updated on 04 Jul 2026, 05:54 AM
scanx
Reviewed by
Riya DScanX News Team
AI Summary

Mukka Proteins Ltd disclosed that its promoters and promoter group did not encumber any shares during FY26. The filing to NSE and BSE under SEBI regulations lists 57 entities, with top promoters holding over 90% of the disclosed equity.

powered bylight_fuzz_icon
44670243

*this image is generated using AI for illustrative purposes only.

Mukka Proteins Ltd confirmed that its promoters and promoter group, along with persons acting in concert, did not create any encumbrance on shares held directly or indirectly during the financial year ended March 31, 2026. This disclosure ensures that the shareholding structure remains unpledged, providing stability to the company's ownership base. The confirmation was submitted to the National Stock Exchange of India Limited and BSE Limited.

The filing was made pursuant to Regulation 31(4) of the SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011. The document was signed by Promoter Mohammed Haris K on April 6, 2026. The disclosure includes a comprehensive list of 57 entities categorized as promoters or promoter group, detailing their respective shareholding status.

The list of promoters and promoter group entities includes individuals and corporate bodies. While several key promoters hold significant equity stakes, a majority of the listed entities hold Nil shares. The disclosure serves as a formal declaration of the non-encumbrance status for the specified financial year.

Shareholding Details

The following table outlines the shareholding of the promoters and promoter group members as disclosed in the filing:

Sl. No. Name Promoter/ Promoter Group No. of Equity Shares held
1 Mohammed Haris K Promoter 9,06,86,800
2 K Mohammed Althaf Promoter 4,84,00,400
3 K Mohammad Arif Promoter 4,84,00,400
4 Kalandan Abdul Razak Promoter Group 2,20,00,000
5 Umaiyya Banu Promoter Group 1,05,11,200
6 Zareena Banu Promoter Group 400
7 Razeena Khatheeja Promoter Group 400
8 Aisha Shabnam Promoter Group 400

The remaining 49 entities listed in the annexure, including various individuals and private limited companies such as Shipwaves Online Limited, Umaya Developers Private Limited, and Sulthan Gold Private Limited, reported Nil shareholdings.

Historical Stock Returns for Mukka Proteins

1 Day5 Days1 Month6 Months1 Year5 Years
-1.07%-3.31%+6.16%+1.54%-22.86%-45.37%

How will the unpledged status of the promoter holdings influence investor confidence and institutional interest in Mukka Proteins?

Does the significant concentration of shares among the top three promoters pose any governance risks for minority shareholders?

What are the company's strategic capital allocation plans given the stable ownership structure and lack of encumbrance?

Mukka Proteins secures partial relief in AY 2018-19 tax appeal

2 min read     Updated on 02 Jul 2026, 03:29 AM
scanx
Reviewed by
Suketu GScanX News Team
AI Summary

Mukka Proteins received a partial relief in its tax appeal for Assessment Year 2018-19, with the CIT (Appeals)-2, Panaji deleting additions totaling ₹8.08 crore, including prior period income of ₹4.48 crore and part of an alleged excess stock addition. However, an addition of ₹7.55 crore related to alleged excess stock was sustained under Section 115BBE, attracting a special tax rate of 78%. The company, having already paid tax at the normal rate, is evaluating the order and considering further legal remedies.

powered bylight_fuzz_icon
44459683

*this image is generated using AI for illustrative purposes only.

Mukka Proteins has secured partial relief in its tax appeal for Assessment Year 2018-19, with the Commissioner of Income Tax (Appeals)-2, Panaji, deleting additions totaling ₹8.08 crore while sustaining a demand of ₹7.55 crore. The appellate order, dated June 30, 2026, addressed disputes arising from an assessment completed under Section 143(3) read with Section 263 of the Income-tax Act, 1961. The order reduces the company's disputed tax liability, though a significant addition remains subject to a higher effective tax rate.

The litigation involved the Assistant Commissioner of Income Tax, Central Circle-1, Mangalore, who had originally made additions totaling ₹15.63 crore. This comprised an alleged excess stock of ₹11.14 crore and prior period income of ₹4.48 crore. The company filed an appeal against these additions, leading to the recent order which provides relief on specific components of the demand.

Breakdown of the Appellate Order

The Commissioner of Income Tax (Appeals) partly allowed the appeal, providing relief on two key counts. The addition of prior period income amounting to ₹4.48 crore was deleted after the authority held that the income had already been offered to tax in earlier assessment years. Additionally, out of the total alleged excess stock of ₹11.14 crore, an addition of ₹3.60 crore was deleted.

Particulars Original Addition Outcome Amount Deleted/Sustained
Prior Period Income ₹4,48,21,141 Deleted ₹4,48,21,141
Alleged Excess Stock ₹11,14,72,010 Partly Deleted ₹3,60,16,402 (Deleted), ₹7,54,55,608 (Sustained)

However, the addition relating to alleged excess stock amounting to ₹7.55 crore has been sustained. This amount is assessed under the special tax rate prescribed under Section 115BBE of the Income-tax Act, which carries an effective rate of 78%. The company stated that it has already discharged the tax liability on this amount at the normal tax rate, which has an effective rate of 34.944%.

Financial Implications and Next Steps

Pursuant to the appellate order, the company has secured a reduction in the taxable demand by ₹8.08 crore. The consequential tax impact will be determined in accordance with the provisions of the Income-tax Act, 1961. The sustained addition of ₹7.55 crore under Section 115BBE remains a point of contention, given the higher effective tax rate applicable to such income.

Mukka Proteins is currently evaluating the appellate order to understand its full financial implications. The company indicated that it is considering appropriate legal remedies available under the law to address the sustained addition. The intimation was submitted to the exchanges in compliance with Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Historical Stock Returns for Mukka Proteins

1 Day5 Days1 Month6 Months1 Year5 Years
-1.07%-3.31%+6.16%+1.54%-22.86%-45.37%

What specific legal remedies is Mukka Proteins considering to challenge the sustained ₹7.55 crore addition under Section 115BBE?

How will the differential between the normal tax rate paid and the 78% effective rate under Section 115BBE impact the company's cash flow and liquidity?

What is the estimated timeline for a final resolution on the remaining disputed amount, and could this lead to further provisions in the upcoming financial statements?

More News on Mukka Proteins

Must Read Next

Earnings

Corporate Actions

Stocks

1 Year Returns:-22.86%